AKTSAktis Oncology, Inc.
$18.14
$18.14
$15.1952 weeks$31.15
What is the market doing?
Mixed
2 neutral, 1 without dataNo clear lean: insiders net selling (often routine) and moderately shorted.
Insider conviction−$455K (90 days to Oct 8, 2026)SEC EDGAR · Oct 8, 2026
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
Short interest6.7% of sharesFINRA · Sep 15, 2026
Moderately shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How AKTS is trading
- Below its 52-week high
- 42%
Below its 52-week high
Details›
- Last close2026-10-09
- $18.14
- 1 monthS&P 500 +2.7%
- −24%
- 52-week high
- $31.15
- 52-week low
- $15.19
- Annualised volatility
- 67%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$3.0M
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
The closest names by size in the same industry